Dr. Reddy’s launches Chlorthalidone Tablets in US Market
Dr. Reddy’s Laboratories has launched Chlorthalidone Tablets USP, 25 mg and 50 mg, a therapeutic equivalent generic version of Hygroton (chlorthalidone) Tablets, approved by the US Food and Drug Administration (USFDA). The Hygroton brand and generic had US sales of around $122 million MAT for the most recent twelve months ending in September 2018 according … Read more
